Boise, ID, United States of America

Eugene P Marsh

USPTO Granted Patents = 206 

 

Average Co-Inventor Count = 1.4

ph-index = 34

Forward Citations = 3,486(Granted Patents)


Inventors with similar research interests:


Location History:

  • Bosie, ID (US) (2013)
  • Boise, ID (US) (1999 - 2020)
  • El Granada, CA (US) (2018 - 2023)

Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Oligonucleic Acid Assembly
Polynucleotide Synthesis
Memory Cells
Metal Chalcogenide
Functionalized Surfaces
Resistive Memory
Conductive Nanoparticles
Phase Change Materials
Semiconductor Devices
Vapor Deposition
Nanotube Structures
Mixed Valence Oxide Memory
206 patents (USPTO):Explore Patents

Title: Eugene P Marsh: Pioneering Innovations in RNA Synthesis and Nucleic Acid Assembly

Introduction:

Eugene P Marsh, an accomplished inventor based in Boise, ID (US), has made significant contributions to the field of RNA synthesis and nucleic acid assembly. With a remarkable number of 206 patents to his name, Marsh has played a crucial role in advancing the development of therapeutic-grade RNA and SiRNA, as well as improving methods and devices for nucleic acid synthesis. In this article, we delve deeper into Marsh's latest patents, highlight his career achievements, and explore his collaborations within the industry.

Latest Patents:

One of Marsh's notable recent patents is "Heated Nanowells for Polynucleotide Synthesis." This invention addresses the challenge of synthesizing modified 3'-end RNA sequences efficiently. By developing reverse RNA monomer phosphoramidites and utilizing a 5'-3' synthesis approach, Marsh has improved the synthesis process, resulting in cleaner oligonucleotide synthesis and allowing for the introduction of various modifications at the 3'-end. This innovative method holds promise in facilitating the development of RNA-based therapies.

Additionally, Marsh has contributed to the field with his patent on "Methods and Devices for De Novo Oligonucleic Acid Assembly." This invention focuses on improving nucleic acid synthesis surfaces, reducing error rates, and increasing nucleic acid mass yield. These advancements are crucial for enabling accurate and efficient de novo nucleic acid synthesis, ultimately benefiting various applications in molecular biology and biotechnology.

Career Highlights:

Marsh's dedication to innovation and his expertise in RNA synthesis and nucleic acid assembly have led him to work with renowned companies in the industry. He has made significant contributions during his tenure at Micron Technology Incorporated and Twist Bioscience Corporation. These collaborations have provided Marsh with a platform to apply his skills and further advance the field.

Collaborations:

During his career, Eugene P Marsh has had the privilege of working alongside talented professionals who have contributed to his success. Notable collaborations include Timothy A Quick and Stefan Uhlenbrock. The collective expertise and shared vision of these colleagues have enhanced the quality and impact of Marsh's inventions and have further enriched the field of RNA synthesis.

Conclusion:

Eugene P Marsh stands as a pioneering figure in the field of RNA synthesis and nucleic acid assembly. With his numerous patents and groundbreaking inventions, Marsh has played a vital role in advancing the development of therapeutic-grade RNA, optimizing oligonucleotide synthesis, and improving de novo nucleic acid assembly methods. His collaborations with esteemed professionals have further enriched his work. Marsh's contributions continue to shape the landscape of molecular biology and hold great promise for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…